Cord Blood-derived Expanded Allogeneic Natural Killer Cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Allogeneic CB-derived Ex vivo-expanded NK Cells, CB-derived Expanded Allogeneic NK Cells, UCB-derived Expanded Allogeneic NK Cells, Umbilical Cord Blood-derived Expanded Allogeneic Natural Killer Cells

Filter by location:

Houston, Texas1 trial

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

M D Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.